Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission
Volume
94
Pagination
1399 - 1406
DOI
10.3324/haematol.2009.008649
Journal
HAEMATOL-HEMATOL J
Issue
ISSN
0390-6078